Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration

Thomas, 1999, Historical markers in the development of allogeneic hematopoietic cell transplantation, Biol Blood Marrow Transplant, 5, 341, 10.1016/S1083-8791(99)70010-8

Friedenstein, 1974, Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo, Transplantation, 17, 331, 10.1097/00007890-197404000-00001

Caplan, 1991, Mesenchymal stem cells, J Orthop Res, 9, 641, 10.1002/jor.1100090504

Alhadlaq, 2004, Mesenchymal stem cells: isolation and therapeutics, Stem Cells Dev, 13, 436, 10.1089/scd.2004.13.436

Le Blanc, 2005, Mesenchymal stem cells: progress toward promise, Cytotherapy, 7, 36, 10.1016/S1465-3249(05)70787-8

Beyer Nardi, 2006, Mesenchymal stem cells: isolation, in vitro expansion and characterization, Handb Exp Pharmacol, 174, 249, 10.1007/3-540-31265-X_11

Conget, 1999, Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells, J Cell Physiol, 181, 67, 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C

Klyushnenkova, 2005, T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J Biomed Sci, 12, 47, 10.1007/s11373-004-8183-7

Kim, 2005, Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell, Cytokine, 31, 119, 10.1016/j.cyto.2005.04.004

Haynesworth, 1996, Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha, J Cell Physiol, 166, 585, 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6

Ries, 2007, MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines, Blood, 109, 4055, 10.1182/blood-2006-10-051060

Honczarenko, 2006, Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors, Stem Cells, 24, 1030, 10.1634/stemcells.2005-0319

Von Luttichau, 2005, Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4, Stem Cells Dev, 14, 329, 10.1089/scd.2005.14.329

Lama, 2007, Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts, J Clin Invest, 117, 989, 10.1172/JCI29713

Chamberlain, 2007, Concise review. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing, Stem Cells, 25, 2739, 10.1634/stemcells.2007-0197

Abdi, 2008, Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes, Diabetes, 57, 1759, 10.2337/db08-0180

Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7

Le Blanc, 2003, Immunomodulatory effects of fetal and adult mesenchymal stem cells, Cytotherapy, 5, 485, 10.1080/14653240310003611

Nasef, 2007, Human bone marrow-derived mesenchymal stem cells, Libyan J Med, 10.4176/070705

Lu, 1996, Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application, Crit Rev Oncol Hematol, 22, 61, 10.1016/1040-8428(96)88370-3

Shlomchik, 2007, Graft-versus-host disease, Nat Rev Immunol, 7, 340, 10.1038/nri2000

Shlomchik, 2007, Transplantation's greatest challenges: advances in chronic graft-versus-host disease, Biol Blood Marrow Transplant, 13, 2, 10.1016/j.bbmt.2006.10.020

Jacobsohn, 2002, Novel therapeutics for the treatment of graft-versus-host disease, Expert Opin Investig Drugs, 11, 1271, 10.1517/13543784.11.9.1271

Jacobsohn, 2002, Novel pharmacotherapeutic approaches to prevention and treatment of GVHD, Drugs, 62, 879, 10.2165/00003495-200262060-00002

Tamada, 2000, Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway, Nat Med, 6, 283, 10.1038/73136

Xu, 2007, Study of relieving graft-versus-host disease by blocking CD137–CD137 ligand costimulatory pathway in vitro, Int J Hematol, 86, 84, 10.1532/IJH97.A10613

Xu, 2007, Predominant immature CD8alpha+ dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence, Eur J Haematol, 78, 235, 10.1111/j.1600-0609.2006.00804.x

Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9

Nauta, 2006, Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting, Blood, 108, 2114, 10.1182/blood-2005-11-011650

Pevsner-Fischer, 2007, Toll-like receptors and their ligands control mesenchymal stem cell functions, Blood, 109, 1422, 10.1182/blood-2006-06-028704

Liotta, 2008, Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling, Stem Cells, 26, 279, 10.1634/stemcells.2007-0454

Tomchuck, 2008, Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses, Stem Cells, 26, 99, 10.1634/stemcells.2007-0563

Ren, 2008, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell, 2, 141, 10.1016/j.stem.2007.11.014

Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182/blood-2006-02-002246

Trinchieri, 1989, Biology of natural killer cells, Adv Immunol, 47, 187, 10.1016/S0065-2776(08)60664-1

Spaggiari, 2008, Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2, Blood, 111, 1327, 10.1182/blood-2007-02-074997

Haynesworth, 1992, Characterization of cells with osteogenic potential from human marrow, Bone, 13, 81, 10.1016/8756-3282(92)90364-3

Le Blanc, 2006, Mesenchymal stem cells: properties and role in clinical bone marrow transplantation, Curr Opin Immunol, 18, 586, 10.1016/j.coi.2006.07.004

Devine, 2002, Mesenchymal stem cells: will they have a role in the clinic?, J Cell Biochem, 38, 73, 10.1002/jcb.10046

Gao, 2001, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, Cells Tissues Organs, 169, 12, 10.1159/000047856

Herrera, 2004, Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury, Int J Mol Med, 14, 1035

Shih, 2005, Restoration of bone defect and enhancement of bone ingrowth using partially demineralized bone matrix and marrow stromal cells, J Orthop Res, 23, 1293, 10.1016/j.orthres.2005.04.005

Wu, 2006, Differentiation potential of human embryonic mesenchymal stem cells for skin-related tissue, Br J Dermatol, 155, 282, 10.1111/j.1365-2133.2006.07357.x

Yoshikawa, 2008, Wound therapy by marrow mesenchymal cell transplantation, Plast Reconstr Surg, 121, 860, 10.1097/01.prs.0000299922.96006.24

Vojtassak, 2006, Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot, Neuro Endocrinol Lett, 27, 134

Keilhoff, 2006, Peripheral nerve tissue engineering: autologous Schwann cells vs. transdifferentiated mesenchymal stem cells, Tissue Eng, 12, 1451, 10.1089/ten.2006.12.1451

Li, 2001, Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease, Neurosci Lett, 316, 67, 10.1016/S0304-3940(01)02384-9

Moviglia, 2006, Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients, Cytotherapy, 8, 202, 10.1080/14653240600736048

Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650

Sonoyama, 2006, Mesenchymal stem cell-mediated functional tooth regeneration in swine, PLoS ONE, 1, e79, 10.1371/journal.pone.0000079

Poh, 2007, Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, ‘off-the-shelf’, cellular cardiomyoplasty strategy, Int J Cardiol, 117, 360, 10.1016/j.ijcard.2006.04.092

Grinnemo, 2004, Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium, J Thorac Cardiovasc Surg, 127, 1293, 10.1016/j.jtcvs.2003.07.037

Noiseux, 2006, Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation, Mol Ther, 14, 840, 10.1016/j.ymthe.2006.05.016

Zhang, 2006, Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source, J Cell Biochem, 99, 1132, 10.1002/jcb.20949

Zhang, 2007, Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair, Transpl Int, 20, 174, 10.1111/j.1432-2277.2006.00407.x

Jo, 2007, Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran, Tissue Eng, 13, 313, 10.1089/ten.2006.0133

Kraus, 2006, Mesenchymal stem cells and bone regeneration, Vet Surg, 35, 232, 10.1111/j.1532-950X.2006.00142.x

Kim, 2005, Musculoskeletal differentiation of cells derived from human embryonic germ cells, Stem Cells, 23, 113, 10.1634/stemcells.2004-0110

Arinzeh, 2003, Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect, J Bone Joint Surg Am, 85A, 1927, 10.2106/00004623-200310000-00010

Fang, 2004, Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice, Transplantation, 78, 83, 10.1097/01.TP.0000128326.95294.14

Shibata, 2008, Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats, Diabetes, 57, 3099, 10.2337/db08-0031

Zhang, 2008, Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy, Exp Clin Endocrinol Diabetes, 116, 104, 10.1055/s-2007-985154

Lee, 2006, Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice, Proc Natl Acad Sci USA, 103, 17438, 10.1073/pnas.0608249103

Hosseinkhani, 2006, Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration, Biomaterials, 27, 5836, 10.1016/j.biomaterials.2006.08.003

Seeherman, 2005, Delivery of bone morphogenetic proteins for orthopedic tissue regeneration, Cytokine Growth Factor Rev, 16, 329, 10.1016/j.cytogfr.2005.05.001

Kirker-Head, 2000, Potential applications and delivery strategies for bone morphogenetic proteins, Adv Drug Deliv Rev, 43, 65, 10.1016/S0169-409X(00)00078-8

Abarrategi, 2008, Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application, Tissue Eng Part A, 14, 1305, 10.1089/ten.tea.2007.0229

Morishita, 2006, Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients’ mesenchymal stem cells, Artif Organs, 30, 115, 10.1111/j.1525-1594.2006.00190.x

Uematsu, 2005, Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold, Biomaterials, 26, 4273, 10.1016/j.biomaterials.2004.10.037

Ouyang, 2003, Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon, Tissue Eng, 9, 431, 10.1089/107632703322066615

Li, 2007, Characteristics of PLGA–gelatin complex as potential artificial nerve scaffold, Colloids Surf B Biointerfaces, 57, 198, 10.1016/j.colsurfb.2007.02.010

Liu, 2008, Fabrication of a PLGA–collagen peripheral nerve scaffold and investigation of its sustained release property in vitro, J Mater Sci Mater Med, 19, 1127, 10.1007/s10856-007-3224-1

Fan, 2006, Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold, Biomaterials, 27, 4573, 10.1016/j.biomaterials.2006.04.013

Caplan, 2007, Adult mesenchymal stem cells for tissue engineering versus regenerative medicine, J Cell Physiol, 213, 341, 10.1002/jcp.21200

Reiser, 2005, Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases, Expert Opin Biol Ther, 5, 1571, 10.1517/14712598.5.12.1571

Li, 2006, Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice, Gene Ther, 13, 1178, 10.1038/sj.gt.3302741

Yang, 2007, Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction, Cardiology, 107, 17, 10.1159/000093609

Zhao, 2006, Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector, J Cereb Blood Flow Metab, 26, 1176, 10.1038/sj.jcbfm.9600273

Kurozumi, 2005, Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model, Mol Ther, 11, 96, 10.1016/j.ymthe.2004.09.020

Zachos, 2007, Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model, Mol Ther, 15, 1543, 10.1038/sj.mt.6300192

Kyriakou, 2006, Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model, J Gene Med, 8, 253, 10.1002/jgm.840

Ren, 2008, Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model, Gene Ther, 15, 1446, 10.1038/gt.2008.101

Ilic, 2008, Latest development in stem cell research and regenerative medicine, Regen Med, 257, 10.2217/17460751.3.3.257

Tyndall, 2007, Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005, Arthritis Res Ther, 9, 301, 10.1186/ar2103

Mishra, 2009, Mesenchymal stem cells: flip side of the coin, Cancer Res, 69, 1255, 10.1158/0008-5472.CAN-08-3562

Hurst, 2007, A MSC-ing link in metastasis?, Nat Med, 13, 1289, 10.1038/nm1107-1289

Ramaswamy, 2007, Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth, Leukemia, 21, 304, 10.1038/sj.leu.2404489

Iwamoto, 2007, Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase, J Clin Invest, 117, 1049, 10.1172/JCI30235

Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188

Bochkov, 2007, Chromosome variability of human multipotent mesenchymal stromal cells, Bull Exp Biol Med, 143, 122, 10.1007/s10517-007-0031-0

Tolar, 2007, Sarcoma derived from cultured mesenchymal stem cells, Stem Cells, 25, 371, 10.1634/stemcells.2005-0620